|
Powered by Cell Signaling Technology |
Site Information |
---|
RKDYPAAkRAKLDsG SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 458888 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on Myc: | |
Effects of modification on biological processes: |
References | |
---|---|
Hurd M, et al. (2023) MYC acetylated lysine residues drive oncogenic cell transformation and regulate select genetic programs for cell adhesion-independent growth and survival. Genes Dev 37, 865-882
37852796 Curated Info |
|
Abdesselem H, et al. (2016) SIRT1 Limits Adipocyte Hyperplasia through c-Myc Inhibition. J Biol Chem 291, 2119-35
26655722 Curated Info |
|
Patel JH, et al. (2004) The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24, 10826-34
15572685 Curated Info |